NYSE:USPH

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. More Details


Snowflake Analysis

Excellent balance sheet with acceptable track record.


Similar Companies

Share Price & News

How has U.S. Physical Therapy's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: USPH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: USPH's weekly volatility (9%) has been stable over the past year.


Market Performance


7 Day Return

0.6%

USPH

1.6%

US Healthcare

2.8%

US Market


1 Year Return

-8.1%

USPH

13.8%

US Healthcare

20.9%

US Market

Return vs Industry: USPH underperformed the US Healthcare industry which returned 13.8% over the past year.

Return vs Market: USPH underperformed the US Market which returned 20.9% over the past year.


Shareholder returns

USPHIndustryMarket
7 Day0.6%1.6%2.8%
30 Day35.4%12.7%12.8%
90 Day20.8%10.0%6.6%
1 Year-7.8%-8.1%15.3%13.8%23.6%20.9%
3 Year52.6%49.2%35.3%29.8%47.3%37.6%
5 Year125.4%115.1%75.9%63.4%94.3%72.9%

Long-Term Price Volatility Vs. Market

How volatile is U.S. Physical Therapy's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is U.S. Physical Therapy undervalued compared to its fair value and its price relative to the market?

45.69x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: USPH ($107.38) is trading above our estimate of fair value ($90.82)

Significantly Below Fair Value: USPH is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: USPH is poor value based on its PE Ratio (45.7x) compared to the US Healthcare industry average (24.1x).

PE vs Market: USPH is poor value based on its PE Ratio (45.7x) compared to the US market (19.7x).


Price to Earnings Growth Ratio

PEG Ratio: USPH is poor value based on its PEG Ratio (2.5x)


Price to Book Ratio

PB vs Industry: USPH is overvalued based on its PB Ratio (5.2x) compared to the US Healthcare industry average (3.2x).


Next Steps

Future Growth

How is U.S. Physical Therapy forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

17.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: USPH's forecast earnings growth (17.9% per year) is above the savings rate (2.2%).

Earnings vs Market: USPH's earnings (17.9% per year) are forecast to grow slower than the US market (22% per year).

High Growth Earnings: USPH's earnings are forecast to grow, but not significantly.

Revenue vs Market: USPH's revenue (8.2% per year) is forecast to grow slower than the US market (10.3% per year).

High Growth Revenue: USPH's revenue (8.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: USPH's Return on Equity is forecast to be low in 3 years time (15.1%).


Next Steps

Past Performance

How has U.S. Physical Therapy performed over the past 5 years?

8.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: USPH has high quality earnings.

Growing Profit Margin: USPH's current net profit margins (7.1%) are higher than last year (6.3%).


Past Earnings Growth Analysis

Earnings Trend: USPH's earnings have grown by 8.4% per year over the past 5 years.

Accelerating Growth: USPH's earnings growth over the past year (1.4%) is below its 5-year average (8.4% per year).

Earnings vs Industry: USPH earnings growth over the past year (1.4%) underperformed the Healthcare industry 22.6%.


Return on Equity

High ROE: USPH's Return on Equity (11.3%) is considered low.


Next Steps

Financial Health

How is U.S. Physical Therapy's financial position?


Financial Position Analysis

Short Term Liabilities: USPH's short term assets ($82.6M) do not cover its short term liabilities ($93.2M).

Long Term Liabilities: USPH's short term assets ($82.6M) exceed its long term liabilities ($76.6M).


Debt to Equity History and Analysis

Debt Level: USPH's debt to equity ratio (6.3%) is considered satisfactory.

Reducing Debt: USPH's debt to equity ratio has reduced from 25.1% to 6.3% over the past 5 years.

Debt Coverage: USPH's debt is well covered by operating cash flow (356.2%).

Interest Coverage: USPH's interest payments on its debt are well covered by EBIT (28.5x coverage).


Balance Sheet


Next Steps

Dividend

What is U.S. Physical Therapy current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate USPH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate USPH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if USPH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if USPH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: USPH is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of USPH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

14.9yrs

Average management tenure


CEO

Chris Reading (56 yo)

16yrs

Tenure

US$2,851,935

Compensation

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer and President of US Physical Therapy Inc. since November 1, 2004. Mr. Reading served as the Chief Operating Officer at ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD2.85M) is below average for companies of similar size in the US market ($USD4.18M).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Reading
President16yrsUS$2.85m0.59%
$ 8.2m
Glenn McDowell
Chief Operating Officer of West15.83yrsUS$1.46m0.11%
$ 1.6m
Lawrance McAfee
Executive Officer & Director16yrsUS$1.57m0.13%
$ 1.8m
Graham Reeve
Chief Operating Officer of East2.67yrsUS$1.55m0.16%
$ 2.2m
Carey Hendrickson
Chief Financial Officerno datano data0.029%
$ 396.0k
Richard Binstein
General Counsel & Secretaryno datano datano data
Jon Bates
VP & Corporate Controller14yrsno datano data
Johnny Blanchard
Assistant Controllerno datano datano data

14.9yrs

Average Tenure

58yo

Average Age

Experienced Management: USPH's management team is seasoned and experienced (14.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christopher Reading
President16yrsUS$2.85m0.59%
$ 8.2m
Lawrance McAfee
Executive Officer & Director16yrsUS$1.57m0.13%
$ 1.8m
Edward Kuntz
Independent Chairman0.50yrUS$260.25k0.056%
$ 773.1k
Mark Brookner
Independent Director22.25yrsUS$241.00k0.13%
$ 1.8m
Clayton Trier
Independent Director15.67yrsUS$265.25k0.085%
$ 1.2m
Bernard Harris
Independent Director15.25yrsUS$247.25k0.18%
$ 2.4m
Kathleen Gilmartin
Independent Director2.5yrsUS$234.75k0.048%
$ 665.8k
Reginald Swanson
Director13.17yrsUS$295.62k0.092%
$ 1.3m
Harry Chapman
Independent Director10.25yrsUS$260.25k0.32%
$ 4.4m

15.3yrs

Average Tenure

68yo

Average Age

Experienced Board: USPH's board of directors are seasoned and experienced ( 15.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: USPH insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

U.S. Physical Therapy, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: U.S. Physical Therapy, Inc.
  • Ticker: USPH
  • Exchange: NYSE
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$1.380b
  • Shares outstanding: 12.85m
  • Website: https://www.usph.com

Number of Employees


Location

  • U.S. Physical Therapy, Inc.
  • 1300 West Sam Houston Parkway South
  • Suite 300
  • Houston
  • Texas
  • 77042
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
USPHNYSE (New York Stock Exchange)YesCommon StockUSUSDMay 1992
UPHDB (Deutsche Boerse AG)YesCommon StockDEEURMay 1992

Biography

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related i...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/29 23:04
End of Day Share Price2020/11/27 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.